KMTS
Kestra Medical Technologies, Ltd.Healthcare · $1.4B market cap
Verdict
We can't put a fair value on KMTS right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.
Business quality
1 of 5 clear the 10% bar. What are the Big Five?
Follow KMTS
Track it on your watchlist and see the full analysis. Free.
Create a free accountInsider activity
Since Sep 8, 2026: no open-market purchases, 4 sales worth $414K and 6 other filings (stock awards, tax withholding and similar). Why purchases matter
Sales
Ladone Mary Kay
director · 2026-09-08
Sold
$98K
Reilly Kevin C
director · 2026-09-08
Sold
$74K
Hanley Conor
director · 2026-09-08
Sold
$144K
Schwartz Jeffrey Lawrence
director · 2026-09-08
Sold
$98K
Other filings
Ladone Mary Kay
director · 2026-09-09
Award
7,217 shares
Reilly Kevin C
director · 2026-09-09
Award
7,217 shares
Hanley Conor
director · 2026-09-09
Award
7,217 shares
COHEN RAYMOND W
director · 2026-09-09
Award
7,217 shares
Kwo Elizabeth
director · 2026-09-09
Award
7,217 shares
Show all 6 other filingsShow fewer
Schwartz Jeffrey Lawrence
director · 2026-09-09
Award
7,217 shares
About Kestra Medical Technologies, Ltd.
Kestra Medical Technologies, Ltd. operates at the intersection of wearable medical technology and digital healthcare. Its core mission is to revolutionize patient outcomes in cardiovascular disease through intelligent, intuitive, and connected monitoring and therapeutic intervention solutions. The company's flagship offering is the Cardiac Recovery System (CRS) platform, which it develops and commercializes. This…
Medical - Instruments & Supplies
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works